PARTNERS

DESTINA Genomica SL is a molecular diagnostic company based in Granada's Health Science Technological Park. The company's origins are focused on the application and validation of its proprietary technology for the direct, PCR-free detection and analysis of nucleic acids. DESTINA has commenced licensing its patented technology under evaluation and development agreements with pharmaceutical, molecular diagnostic and analytical platform companies, as well as the manufacturing and supply of custom molecules for research purposes.

LogoDestinaPartners.png

OPTOI SRL is an Italian SME born in 1995 as a spin-off company from the  FBK research institute (Trento). Its core business focuses on microelectronic packaging, especially on optoelectronic sensors. In over twenty years of activity, Optoi has become a supplier of reference for the industrial and special vehicle sectors, while in recent years it is also conducting important projects in the aerospace and biomedical fields with the development of innovative photonic devices for the detection of circulating biomarkers.

LogoOptoiPartners.png

NanoGetic SL is a Spanish biotech company placed in the Health’s Technology Park (PTS). NanoGetic operates in the field of nano-biotechnology specializations that make it unique in the Spanish national scene and one of the few worldwide offering the design and production of innovative and customizable nanosystems. The company provides an ad-hoc multifunctionalization of nanoparticles. It has a highly qualified and internationally recognized team, state-of-the-art laboratory capabilities, standardized protocols and know-how to develop  and validate nanoparticles in biotechnological applications.

LogoNanogeticPartners.png

Comprehensive center for research and treatment of pediatric cancer. The Princess Máxima Center for Pediatric Oncology is the largest, nationally centralized pediatric cancer center in Europe. Their mission is “to provide a cure and optimal quality of life for every child with cancer.” The Center currently houses more than 30 research groups and fosters close ties between research and patient care. In line with our mission, the Princess Máxima Center strongly encourages projects that translate preclinical studies into clinical applications. 

The research group of the Princess Máxima Center participating in diaRNAgnosis involves people from the group of Prof. Leendert Looijenga (link).

LogoPrincessMaximaPartners.png

The University of Trento (UNITN) is an University in the Autonomous Province of Trento (PAT), Italy, that is characterized by a high level of public investment in innovation. UNITN provides an ideal environment for study and research and ranked first among Italian State Universities in the The Research Quality Assessment released by ANVUR. CIBIO, the involved Department in this project, is currently home to 39 independent research groups, focusing in Cancer Biology and Genomics, Cell and Molecular Biology, Microbiology and Synthetic Biology, Neurobiology and Development. 

The research group of the University of Trento participating in diaRNAgnosis involves people from the Laboratory of RNA Biology and Biotechnology lead by Prof. Michela A. Denti (link).

LogoUNITNPartners.png

The University of Catania (UNICT) is a University located in Catania (Italy). It is the  oldest  of  the  Italian  South-Centre  universities (founded in 1434). UNICT manifests some excellences in terms of didactics and research thanks to particular  synergies  and  specific  collaborations  with  several  research institutes  operating  in  its  territory.  UNICT is the recipient of research funding at international and national level and it has a long-term involvement in different research programs, both as a coordinator and/or a partner. 

The University of Catania participates in diaRNAgnosis involving the research groups of Prof. Cinzia Di Pietro and Prof. Marco Ragusa. (link).

LogoUNICTPartners.png

The University of Granada (UGR) is an internationally renowned institution, committed to being at the forefront of developing technologies, and a centre of excellence for academic research. Among the merits of the UGR, it has been recognized as the first European University in number of foreign students, the first Andalusian University (third in Spain) in doctoral courses with the distinction of quality granted by the Ministry of Education and Science, and the first Andalusian University (sixth in Spain) in scientific production.

The University of Granada is involved in diaRNAgnosis through the research groups of Prof. Rosario Mª Sánchez Martin (link) and Prof, Ángel Orte (link). 

LogoUGRPartners.png